These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8018559)

  • 1. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S; Huang F; Hafez M; Winawer S; Friedman E
    Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM; Infante D; Winawer S; Friedman E
    Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A; Gold LI; Wang J; Cohen A; Friedman E
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nm23 in transforming growth factor beta 1-mediated adherence and growth arrest.
    Hsu S; Huang F; Wang L; Banerjee S; Winawer S; Friedman E
    Cell Growth Differ; 1994 Sep; 5(9):909-17. PubMed ID: 7819128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect.
    Hsu S; Huang F; Friedman E
    J Cell Physiol; 1995 Nov; 165(2):239-45. PubMed ID: 7593201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
    Wu SP; Sun LZ; Willson JK; Humphrey L; Kerbel R; Brattain MG
    Cell Growth Differ; 1993 Feb; 4(2):115-23. PubMed ID: 8494782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
    Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
    Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two roles for transforming growth factor beta 1 in colon enterocytic cell differentiation.
    Hafez MM; Hsu S; Yan Z; Winawer S; Friedman E
    Cell Growth Differ; 1992 Nov; 3(11):753-62. PubMed ID: 1334691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
    Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
    Zipfel PA; Ziober BL; Morris SL; Mulder KM
    Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells.
    Shimizu S; Nishikawa Y; Kuroda K; Takagi S; Kozaki K; Hyuga S; Saga S; Matsuyama M
    Cancer Res; 1996 Jul; 56(14):3366-70. PubMed ID: 8764135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J
    Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
    Hasina R; Matsumoto K; Matsumoto-Taniura N; Kato I; Sakuda M; Nakamura T
    Br J Cancer; 1999 Aug; 80(11):1708-17. PubMed ID: 10468286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
    Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
    Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.